Table 3

Prevalence of any impaired glucose metabolism (IGM), impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and diabetes, overall and by sex and age group, among 2559 participants with a Finnish Diabetes Risk Score (FINDRISC) ≥15 and no previously known diabetes

IGMIFGIGTDiabetes
Prevalence, % (95% CI)Prevalence ratio (95% CI)Prevalence, % (95% CI)Prevalence ratio (95% CI)Prevalence, % (95% CI)Prevalence ratio (95% CI)Prevalence, % (95% CI)Prevalence ratio (95% CI)
Overall34.9 (33.1 to 36.8)8.2 (7.2 to 9.3)16.9 (15.5 to 18.4)9.8 (8.7 to 11.1)
Sex
 Men40.4 (37.4 to 43.4)1.00 (Reference)9.7 (8.1 to 11.7)1.00 (Reference)17.9 (15.6 to 20.3)1.00 (Reference)12.8 (10.9 to 14.9)1.00 (Reference)
 Women31.2 (28.9 to 33.6)0.77 (0.70 to 0.86)7.1 (5.9 to 8.5)0.73 (0.56 to 0.94)16.2 (14.5 to 18.2)0.91 (0.76 to 1.08)7.9 (6.6 to 9.3)0.62 (0.49 to 0.78)
Age, years
 20 to 3919.1 (12.3 to 28.5)1.00 (Reference)4.3 (1.6 to 11.0)1.00 (Reference)11.7 (6.5 to 20.1)1.00 (Reference)3.2 (1.0 to 9.6)1.00 (Reference)
 40 to 4923.3 (18.6 to 28.9)1.22 (0.76 to 1.95)6.9 (4.4 to 10.7)1.62 (0.56 to 4.67)10.7 (7.5 to 15.1)0.92 (0.48 to 1.77)5.7 (3.5 to 9.3)1.80 (0.53 to 6.08)
 50 to 5930.8 (27.3 to 34.6)1.61 (1.05 to 2.48)10.1 (8.0 to 12.7)2.37 (0.88 to 6.36)11.8 (9.5 to 14.6)1.01 (0.56 to 1.84)8.9 (6.9 to 11.4)2.81 (0.90 to 8.80)
 60 to 6936.9 (33.6 to 40.2)1.93 (1.26 to 2.95)9.6 (7.8 to 11.8)2.25 (0.84 to 6.02)16.2 (13.8 to 18.8)1.38 (0.78 to 2.46)11.1 (9.1 to 13.4)3.50 (1.13 to 10.84)
 70 to 7938.7 (34.9 to 42.6)2.02 (1.32 to 3.10)6.1 (4.5 to 8.4)1.44 (0.53 to 3.96)22.6 (19.4 to 26.1)1.93 (1.09 to 3.43)9.9 (7.8 to 12.6)3.13 (1.00 to 9.77)
 ≥8055.5 (47.5 to 63.3)2.90 (1.87 to 4.50)5.2 (2.6 to 10.2)1.23 (0.38 to 3.97)32.7 (25.7 to 40.6)2.79 (1.53 to 5.09)17.6 (12.3 to 24.6)5.55 (1.73 to 17.80)